Temporal transcriptomics identifies early-response and infection-condition-specific modules guiding host-directed anti-EBOV therapeutics. [PDF]
Zhang N +9 more
europepmc +1 more source
Viral RNA persistence and long-term consequences following acute infection with Risk Group 4 zoonotic viruses. [PDF]
Li H, Pickering BS.
europepmc +1 more source
Confirming ERVEBO Vaccination to Support Ebola Virus Surveillance. [PDF]
Karaaslan E +19 more
europepmc +1 more source
Oral immunization with filovirus-like particles partially protects IFNAR<sup>-</sup>/<sup>-</sup> mice against lethal ebola virus challenge. [PDF]
Escudero-Pérez B +11 more
europepmc +1 more source
Characterization of atypical Ebola virus disease in ferrets. [PDF]
Cao W +19 more
europepmc +1 more source
Nanobody targeting glycan cap confers broad orthoebolavirus neutralization. [PDF]
Zhang X +10 more
europepmc +1 more source
Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor. [PDF]
Ye G +7 more
europepmc +1 more source
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans. [PDF]
Khurana S +15 more
europepmc +1 more source
Transcriptional signatures of rapid protection from Sudan virus infection by a single dose of a vesicular stomatitis virus-based vaccine. [PDF]
Doratt BM +5 more
europepmc +1 more source
QSAR-Guided and Fragment-Based Drug Design of Monoterpenoid Inhibitors Targeting Ebola Virus Glycoprotein. [PDF]
Ait Lahcen N +8 more
europepmc +1 more source

